Lung adenocarcinoma
Lung adenocarcinoma is a type of lung cancer and belongs to non-small cell carcinoma. Unlike squamous cell lung cancer, lung adenocarcinoma is more likely to occur in women and non-smokers. It originates from the bronchial mucosal epithelium, and a few originate from the mucous glands of large bronchi. The incidence rate is lower than that of squamous cell carcinoma and undifferentiated carcinoma, the age of onset is younger, and it is relatively more common in women. Most adenocarcinomas originate from smaller bronchi and are peripheral lung cancers. There are generally no obvious clinical symptoms in the early stages, and they are often discovered during chest X-ray examinations. They appear as round or oval masses, which generally grow slowly, but sometimes blood metastasis occurs in the early stages. Lymphatic metastasis occurs later.
Related Drugs
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Manufacturer:
Huaren Pharmaceutical Co., Ltd.
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Manufacturer:
Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd.
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Manufacturer:
Shijiazhuang No.4 Pharmaceutical Co., Ltd.
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Manufacturer:
Harbin Medisan Pharmaceutical Co., Ltd.
Fluorouracil Sodium Chloride Injection
Indication: 1. Used as adjuvant chemotherapy and palliative treatment for breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system cancer and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma. 2. Main chemotherapy drug for the treatment of malignant hydatidiform mole and choriocarcinoma. 3. Head and neck malignancies and liver cancer.
Fluorouracil for injection
Indication: 1. This product can be used for adjuvant and palliative treatment of breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system tumors and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma; 2. It can be used to treat malignant hydatidiform mole and choriocarcinoma; 3. It can be used for intensive intra-arterial chemotherapy of serous cavity cancerous effusion and bladder cancer; 4. It can be used for intra-arterial catheter chemotherapy of head and neck malignant tumors and liver cancer.
Manufacturer:
Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.
Fluorouracil for injection
Indication: 1. This product can be used for adjuvant and palliative treatment of breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system tumors and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma; 2. It can be used to treat malignant hydatidiform mole and choriocarcinoma; 3. It can be used for intensive intra-arterial chemotherapy of serous cavity cancerous effusion and bladder cancer; 4. It can be used for intra-arterial catheter chemotherapy of head and neck malignant tumors and liver cancer.
Manufacturer:
Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.
Fluorouracil for injection
Indication: 1. This product can be used for adjuvant and palliative treatment of breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system tumors and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma; 2. It can be used to treat malignant hydatidiform mole and choriocarcinoma; 3. It can be used for intensive intra-arterial chemotherapy of serous cavity cancerous effusion and bladder cancer; 4. It can be used for intra-arterial catheter chemotherapy of head and neck malignant tumors and liver cancer.
Manufacturer:
Shanxi PUDE Pharmaceutical Co., Ltd.
Fluorouracil for injection
Indication: 1. This product can be used for adjuvant and palliative treatment of breast cancer, digestive tract cancer (including primary and metastatic liver cancer, biliary system tumors and pancreatic cancer), ovarian cancer and primary bronchopulmonary adenocarcinoma; 2. It can be used to treat malignant hydatidiform mole and choriocarcinoma; 3. It can be used for intensive intra-arterial chemotherapy of serous cavity cancerous effusion and bladder cancer; 4. It can be used for intra-arterial catheter chemotherapy of head and neck malignant tumors and liver cancer.
Manufacturer:
Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Co., Ltd.